Greenfern Industries Limited (GFI) has reported unaudited results for the year ending 31 March 2022, with net loss attributable to shareholders of $1.95 million, unaudited net tangible assets per quoted equity security of $0.04241461, and unaudited net assets of NZ$3.63 million.

The company has made progress in its five months of being listed, signing a Master Services Agreement with an Australian company, becoming New Zealand's first certified medicinal cannabis B-Corp Company, and commencing the writing of clinical trial protocols in pursuit of the Australian over-the-counter low dose CBD market.

GFI Chief Financial Officer Hao Long said, “The compliance listing in October 2021 was a significant milestone for the company and has provided the platform to continue our future expansion.”

See more